US Stocks
/
Kairos Pharma, Ltd. Share Price
Kairos Pharma, Ltd. Share Price

Kairos Pharma, Ltd. Share Price

AMEX: KAPA | Micro Cap
$0.80
-$0.12 (-12.99%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Kairos Pharma, Ltd. Stock Performance

Open
$0.97
Prev. Close
$0.93
Circuit Range
N/A
Day Range
$0.79 - $0.97
Year Range
$0.22 - $2.15
Volume
1,768
Average Traded
$0.91

Kairos Pharma, Ltd. Share Price Today

As of 11 October 2026, Kairos Pharma, Ltd.'s share price is $0.80. The stock opened at $0.97, compared to its previous close of $0.93. During today's trading session, Kairos Pharma, Ltd.'s share price traded between $0.79 and $0.97, with an average price of $0.88. Over the past 52 weeks, the stock has recorded a high of $2.15 and a low of $0.22. In terms of performance, Kairos Pharma, Ltd.'s share price has risen by 41.21% over the last six months and is down 27.16% on a year-on-year basis.

Kairos Pharma, Ltd. Share Price Chart

$0.79$0.97
L
Show Current Price
H

Kairos Pharma, Ltd. Stock Fundamentals & Key Indicators

Market Cap
$14.83M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.71
Revenue (TTM)
$0.00
Return On Equity (TTM)
-138.51%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
0.71%

Kairos Pharma, Ltd. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$1.40-$1.37-$1.65-$1.39
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A2.14%-20.44%15.76%

Kairos Pharma, Ltd. Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$0.00
Net Profit-$2.60-$5.45
Net Profit MarginN/AN/A
Income ChangeN/A-109.62%

About Kairos Pharma, Ltd.

Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. The company is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. The product portfolio of the company consists of Pre-clinical or clinical-trial stage drug candidates, Therapeutic agents, and other technologies for treating diseases.

Kairos Pharma, Ltd. Historical Returns

MonthOpenCloseChange %
Oct 2026
$1.55
$0.80
-52.26%
Sep 2026
$1.59
$1.68
+594.21%
Aug 2026
$0.30
$0.24
-22.68%
Jul 2026
$0.37
$0.31
-19.74%
Jun 2026
$0.50
$0.39
-22.16%
May 2026
$0.56
$0.50
-12.11%
Apr 2026
$0.55
$0.57
+1.60%
Mar 2026
$0.62
$0.56
-8.18%
Feb 2026
$0.68
$0.61
-10.15%
Jan 2026
$0.72
$0.68
-4.36%
Dec 2025
$0.79
$0.71
-5.07%
Nov 2025
$1.06
$0.75
-32.22%

KAPA Share Price FAQs

What is Kairos Pharma, Ltd. share price today?

chevron-up
Kairos Pharma, Ltd. share price today is $0.80 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Kairos Pharma, Ltd. stock?

chevron-up
The 52 week high of Kairos Pharma, Ltd. stock is $2.15, while the 52 week low is $0.22 as of 10 Oct '26.

What is KAPA's market capitalisation today?

chevron-up
KAPA market capitalisation is $14.83M as of October 11, 2026, at 2:59 am IST.

What is KAPA's net income for the last quarter?

chevron-up
KAPA's net income for the last quarter is -1.39B USD.

What is the 5 year returns of KAPA?

chevron-up
The 5 year returns of KAPA is -48.73% as on 10 Oct '26.

What is the high & low stock price of KAPA today?

chevron-up
KAPA stock price hit a high of $0.97 and low of $0.79 as of 10 Oct '26.

Can I buy KAPA shares in India?

chevron-up
Yes. You can buy KAPA in India by opening an international trading account.